Seattle Genetics

Padcev

Manufacturer:

Seattle Genetics

Padcev HCPCS:

J9177

HCPCS Code Descriptor:

Injection, enfortumab vedotin-ejfv, 0.25 mg

Category:

J Code

Padcev NDCs:

51144-0030-01, 51144-0020-01

Primary Type:

Oncology

Generic/Specialty Status:

Single-Source

Route of Administration:

Intravenous

Potential NDC Listing Errors:

Our team did not identify any potential listing errors/discrepancies for the NDCs mapped to this HCPCS code.

About Padcev:

Padcev is an Oncology drug manufactured by Seattle Genetics and administered via the Intravenous route of administration. The J Code: J9177 is aligned to the drug Padcev.

ACCESS PRICING AND MORE BY REGISTERING

J9177 Added Date:

July 1, 2020

J9177 Effective Date:

July 1, 2020

J9177 Termination Date:

HCPCS Active

Padcev billing and coding information can be found through Seattle Genetics at the link below:
Padcev patient assistance information can be found through Astellas Pharma’s Support Solutions at the URL: https://astellaspharmasupportsolutions.com/patient/padcev/index.aspx
Padcev prescribing information can be found at the link below:
Information regarding Padcev’s side effects can be found at MedlinePlus